๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Quetiapine: Results of four phase II and III clinical trials

โœ Scribed by D.J. King

Book ID
119573513
Publisher
Elsevier Science
Year
1998
Tongue
French
Weight
458 KB
Volume
13
Category
Article
ISSN
0924-9338

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

PLAY THE WINNER FOR PHASE II/III CLINICA
PLAY THE WINNER FOR PHASE II/III CLINICAL TRIALS
โœ Q. YAO; L. J. WEI ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 642 KB

In comparing two treatments under a typical sequential clinical trial setting, a 50-50 randomization design generates reliable data for making efficient inferences about the treatment difference for the benefit of patients in the general population. However, if the treatment difference is large and

Evaluation of gadobenate dimeglumine in
Evaluation of gadobenate dimeglumine in hepatocellular carcinoma: Results from phase II and phase III clinical trials in Japan
โœ Akihiro Tanimoto; Ryohei Kuwatsuru; Masumi Kadoya; Kuni Ohtomo; Shinji Hirohashi ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 794 KB

To evaluate the clinical efficacy of gadobenate dimeglumine (Gd-BOPTA)-enhanced magnetic resonance imaging for hepatocellular carcinoma (HCC), we reviewed the results of clinical phase II and III trials in Japan. Gd-BOPTA was administered at a dose of 0.1 mmol/kg to 139 patients who were suspected t